206 related articles for article (PubMed ID: 31332036)
1. TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
Ye H; Guo X
Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31332036
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and therapeutic potential of the long noncoding RNA TP73-AS1 in cancers: A systematic review and meta-analysis.
Zhong Y; Zhao M; Yu Y; Li Q; Wang F; Wu P; Zhang W; Miao L
Sci Rep; 2020 Jun; 10(1):9053. PubMed ID: 32493915
[TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
4. High Expression of KIF20A Is Associated with Poor Overall Survival and Tumor Progression in Early-Stage Cervical Squamous Cell Carcinoma.
Zhang W; He W; Shi Y; Gu H; Li M; Liu Z; Feng Y; Zheng N; Xie C; Zhang Y
PLoS One; 2016; 11(12):e0167449. PubMed ID: 27941992
[TBL] [Abstract][Full Text] [Related]
5. MicoRNA-425-5p is a potential prognostic biomarker for cervical cancer.
Sun L; Jiang R; Li J; Wang B; Ma C; Lv Y; Mu N
Ann Clin Biochem; 2017 Jan; 54(1):127-133. PubMed ID: 27166306
[TBL] [Abstract][Full Text] [Related]
6. Aberrant TIMELESS expression is associated with poor clinical survival and lymph node metastasis in early-stage cervical carcinoma.
Zhang W; He W; Shi Y; Zhao J; Liu S; Zhang F; Yang J; Xie C; Zhang Y
Int J Oncol; 2017 Jan; 50(1):173-184. PubMed ID: 27909716
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of TP73 profile prognostic significance in WHO grade II/III glioma.
Chen Y; Wang Y; He Q; Wang W; Zhang T; Wang Z; Dong J; Lan Q; Zhao J
Cancer Med; 2021 Jul; 10(13):4644-4657. PubMed ID: 34121368
[TBL] [Abstract][Full Text] [Related]
8. GINS2 is a novel prognostic biomarker and promotes tumor progression in early-stage cervical cancer.
Ouyang F; Liu J; Xia M; Lin C; Wu X; Ye L; Song L; Li J; Wang J; Guo P; He M
Oncol Rep; 2017 May; 37(5):2652-2662. PubMed ID: 28405687
[TBL] [Abstract][Full Text] [Related]
9. Predictive significance of combined LAPTM4B and VEGF expression in patients with cervical cancer.
Meng F; Tan S; Liu T; Song H; Lou G
Tumour Biol; 2016 Apr; 37(4):4849-55. PubMed ID: 26526574
[TBL] [Abstract][Full Text] [Related]
10. microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
Park S; Kim J; Eom K; Oh S; Kim S; Kim G; Ahn S; Park KH; Chung D; Lee H
BMC Cancer; 2019 May; 19(1):419. PubMed ID: 31060525
[TBL] [Abstract][Full Text] [Related]
11. Expression of IL-1α and IL-6 is Associated with Progression and Prognosis of Human Cervical Cancer.
Song Z; Lin Y; Ye X; Feng C; Lu Y; Yang G; Dong C
Med Sci Monit; 2016 Nov; 22():4475-4481. PubMed ID: 27866212
[TBL] [Abstract][Full Text] [Related]
12. C14ORF166 overexpression is associated with pelvic lymph node metastasis and poor prognosis in uterine cervical cancer.
Zhang W; Ou J; Lei F; Hou T; Wu S; Niu C; Xu L; Zhang Y
Tumour Biol; 2016 Jan; 37(1):369-79. PubMed ID: 26219895
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
[TBL] [Abstract][Full Text] [Related]
14. High TRIM44 expression as a valuable biomarker for diagnosis and prognosis in cervical cancer.
Liu S; Meng F; Ding J; Ji H; Lin M; Zhu J; Ma R
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30792262
[TBL] [Abstract][Full Text] [Related]
15. TP73-AS1 as a predictor of clinicopathological parameters and prognosis in human malignancies: a meta and bioinformatics analysis.
Chen C; Wang J; Feng Y; Liang Y; Huang Y; Zou W
BMC Cancer; 2022 May; 22(1):581. PubMed ID: 35614413
[TBL] [Abstract][Full Text] [Related]
16. CCT6A may act as a potential biomarker reflecting tumor size, lymphatic metastasis, FIGO stage, and prognosis in cervical cancer patients.
Ma J; Yang L; Feng H; Zheng L; Meng H; Li X
J Clin Lab Anal; 2021 Aug; 35(8):e23793. PubMed ID: 34196992
[TBL] [Abstract][Full Text] [Related]
17. NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.
Ma Y; Kong J; Yan G; Ren X; Jin D; Jin T; Lin L; Lin Z
BMC Cancer; 2014 Jun; 14():414. PubMed ID: 24912939
[TBL] [Abstract][Full Text] [Related]
18. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
19. High expression of Kruppel-like factor 4 as a predictor of poor prognosis for cervical cancer patient response to radiotherapy.
Liu HX; Li N; Wei L; Zhou FX; Ma R; Xiao F; Zhang W; Zhang Y; Hui YP; Song H; Chen BL
Tumour Biol; 2017 Jun; 39(6):1010428317710225. PubMed ID: 28639905
[TBL] [Abstract][Full Text] [Related]
20. Special AT-rich sequence-binding protein 1: a novel biomarker predicting cervical squamous cell carcinoma prognosis and lymph node metastasis.
Wang S; Wang L; Zhang Y; Liu Y; Meng F; Ma J; Shang P; Gao Y; Huang Q; Chen X
Jpn J Clin Oncol; 2015 Sep; 45(9):812-8. PubMed ID: 26117495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
